glp-1 therapies The Benefits of Therapy: Beyond Weight Loss The GLP-1 revolution: What UAB
Description
doi: 10.1210/jc.2014-2674% 63 SunMXQiaoFXXuZRLiuYCXuCLWangHLet al
Ala 21 The mutation of GLP-1 Glu 27 to Ala does not change the affinity but slightly increases activity
Glickman says
Safety and efficacy of weekly pemvidutide versus placebo for metabolic dysfunction-associated steatohepatitis (IMPACT): 24-week results from a multicentre, randomised, double-blind, phase 2b study
The scale tells one story
Glucagon-like Peptide-1 Receptor Agonists: A Class Update for Treating Type 2 Diabetes
